EXPERT

• Research type

  Research Study

• Full title

  Expert: A Phase II study of Oxaliplatin [Eloxatin] Capecitabine [Xeloda] and pre-operative radiotherapy for patinets with locally advanced and inoperable rectal cancer.

• Contact name

  David Cunningham

• Contact email

  david.cunningham@rmh.nhs.uk;jacqui.oates@rmh.nhs.uk

• Eudract number

  N/A

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• REC name

  South Central - Oxford A Research Ethics Committee

• REC reference

  CCR1973

• Date of REC Opinion

  20 May 2011

• REC opinion

  Favourable Opinion